Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+11.5%
5Y CAGR+397.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+11.5%/yr
vs +603.2%/yr prior
5Y CAGR
+397.9%/yr
Recent deceleration
Acceleration
-591.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3060.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $56.49M | +516.4% |
| 2023 | $9.17M | +27.5% |
| 2022 | $7.19M | -82.4% |
| 2021 | $40.75M | +192.0% |
| 2020 | $13.95M | +75500.1% |
| 2019 | $18457.00 | -95.1% |
| 2018 | $379557.00 | +2177.6% |
| 2017 | $16665.00 | +38.5% |
| 2016 | $12036.00 | - |